|
[Related PubMed/MEDLINE]
Total Number of Papers: 23
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: CysLT1 |
| Long Form |
: cysteinyl leukotriene receptor 1 |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A simple and sensitive HPLC-MS/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study. |
--- |
| 2 |
2019 |
Cysteinyl leukotriene receptor antagonism: a promising pharmacological strategy for lowering the severity of arthritis. |
MMP |
| 3 |
2018 |
Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma. |
LTRAs |
| 4 |
2018 |
New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses. |
LTD4, MCTR |
| 5 |
2017 |
Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain. |
5-LO, CNS, cPLA2alpha, LTs |
| 6 |
2017 |
Screening of Sceptridium ternatum for antitussive and antiasthmatic activity and associated mechanisms. |
--- |
| 7 |
2014 |
5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. |
5-LOX, EGF, LTC4, Tiam1 |
| 8 |
2014 |
Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate. |
5-LO, LRRC8A, RES, WT |
| 9 |
2013 |
Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. |
cAMP, FPR2, GTPgamma, IL, LX |
| 10 |
2012 |
Resolvins as new fascinating drug candidates for inflammatory diseases. |
GPR32, PMN |
| 11 |
2012 |
The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. |
CLL, CysLT, GPCR |
| 12 |
2010 |
Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats. |
AST, CL, I/R, LDH, MDA, MPO |
| 13 |
2009 |
Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. |
DCs |
| 14 |
2008 |
Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. |
NHLs, PMBCL |
| 15 |
2007 |
A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate. |
CysLT2 |
| 16 |
2006 |
Montelukast protects against renal ischemia/reperfusion injury in rats. |
AOC, CL, I/R, LDH, MDA, MPO |
| 17 |
2006 |
Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury. |
--- |
| 18 |
2006 |
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. |
--- |
| 19 |
2005 |
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. |
MCAO |
| 20 |
2005 |
ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats. |
NMDA, VCAM-1 |
| 21 |
2005 |
Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. |
MCAO |
| 22 |
2003 |
Benefit-risk assessment of antileukotrienes in the management of asthma. |
--- |
| 23 |
2001 |
Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. |
HASM, IFN, LT, mRNA |
|
A Search Service for Abbreviation / Long Form
